SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biohaven is trending after its experimental depression treatment, BHV-7000, failed to meet its primary endpoint in a Phase 2 study, leading the company to halt further psychiatric trials for the drug. Despite the setback, which analysts widely deemed "disappointing but not surprising," community focus is now strongly shifting to the company's broader pipeline, especially upcoming pivotal data for its epilepsy program and other key immunology and obesity assets.

TOSHI

TOSHI is trending as its community actively "buys the dip," driven by recent exchange listings like Coinone KRW and an "oversold" market status. Discussion centers on its foundational utility on the Base network as the "Face of Base," robust community support, and anticipation of further tier-one listings, positioning it distinctly among meme coins.

Coeur Mining, Inc. engages in the well-diversified, growing precious metals producer with a focus on generating sustainable, high-quality cash flow and returns from a balanced, prospective asset base in mining-friendly jurisdictions along with commitment to exploration and expansions. It operates through the following segments: Palmarejo, Rochester, Kensington, Wharf and Silvertip. The Palmarejo segment includes a gold-silver complex. The Rochester segment operates an open pit heap leach silver-gold mine in northwestern Nevada. The Kensington segment relates to an underground gold mine located north of Juneau, Alaska. The Wharf segment focuses on an open pit heap leach gold mine located near Lead, South Dakota. The Silvertip segment silver-zinc-lead exploration located in the state of Sonora in northern Mexico. The company was founded in 1928 and is headquartered in Chicago, IL.

Coeur Mining Inc

Coeur Mining Inc. is a key discussion point following its strategic $7 billion acquisition of New Gold, positioning it as a major North American precious metals producer amidst a strong bull market for gold and silver. The community is actively discussing CDE's robust Q3 earnings and silver's record highs, with many anticipating significant upside as institutional interest grows in the mining sector.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is drawing significant attention following positive clinical data for Tradipitant in addressing GLP-1 induced nausea and vomiting, coupled with multiple near-term regulatory decisions for its pipeline. The community is vigorously debating the stock's undervaluation and considerable growth potential from these catalysts, particularly Tradipitant's role in the expanding GLP-1 market.

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals is trending as analysts reaffirm confidence in its Kv7 drug pipeline, emphasizing that Biohaven's recent depression study miss has limited negative read-through for XENE's distinct azetukalner program. The community is actively discussing the stock's strong analyst ratings and the highly anticipated Phase 3 epilepsy data expected in early 2026, which continues to drive bullish sentiment around its differentiated therapeutic profile.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines, Inc.

Unusual Machines, Inc. is trending amid anticipation of an impending FCC ban on Chinese drone components, which is expected to create a significant demand for its U.S.-made, NDAA-compliant parts. The community is buzzing about the company's strategic positioning to capture a large share of the rapidly expanding domestic drone market, further fueled by recent multi-million dollar purchase orders and its reported profitability. This focus on American-made drone technology, supported by major defense spending initiatives, positions UMAC as a key player in the unfolding "Drone Dominance" narrative.

Draganfly, Inc. engages in the manufacture and sale of commercial unmanned aerial vehicle systems and software serving the public safety, agriculture, industrial inspections, security, mapping, and surveying markets. Its products include quad-copters, fixed wing aircrafts, ground based robots, hand held controllers, and software used for tracking, live streaming, and data collection. The firm also offers custom engineering, training, simulation consulting, as well as data and flight training services. The company was founded by Zenon Dragan and Christine Dragan in 1998 and is headquartered in Saskatoon, Canada.

Draganfly Inc

Draganfly is trending due to a confluence of positive developments, including recent international military orders for its Commander 3XL and successful demonstrations of its Outrider drone for U.S. border security. The community is actively discussing Draganfly's strategic position as an undervalued, NDAA-compliant pure-play, poised to capitalize on the rapidly expanding drone sector driven by increasing military and commercial demand, especially as the U.S. military eyes a massive ramp-up in drone acquisitions.

Sprott Physical Silver Trust - Units

Sprott Physical Silver Trust ET

Sprott Physical Silver Trust (PSLV) is trending as silver surges to historic highs, fueled by mounting industrial demand from sectors like EVs and AI, coupled with persistent structural supply deficits. The community is abuzz with "silver squeeze" narratives, actively discussing the metal's critical role and perceived undervaluation, with many anticipating significant price appreciation amidst concerns over market manipulation and global monetary policy shifts.

ProShares Trust - ProShares UltraShort Silver -2x Shares

ProShares UltraShort Silver

ProShares UltraShort Silver ($ZSL) is trending as the community hotly debates the sustainability of silver's recent rally, with many anticipating a significant pullback for the metal. Traders are actively initiating or adding to short positions, betting that silver is overbought and due for a correction, citing the historical tendency of parabolic moves to reverse. However, some caution against shorting precious metals in the current macro environment, highlighting the inherent risks and historical underperformance of inverse leveraged ETFs over time.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as the Federal Reserve implemented a rate cut and initiated Treasury bill purchases, sparking a divided market discussion. While many anticipate further downside for long-duration bonds amid persistent inflation fears and concerns about Fed policy effectiveness, a vocal group views this as an opportune entry, betting on TLT to rise significantly as deeper economic weakness or future aggressive rate cuts drive a flight to safety. The ongoing speculation around a new, politically influenced Fed chair further complicates the outlook for bond yields.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Actionable Trade Alert for $ATO:

Market Context: $ATO is currently trading at $168.21, showing a bearish sentiment as indicated by the RSI of 38.82, suggesting oversold conditions. The stock is below both the 30-day MA of 173.03 and the 50-day MA of 174.04, reinforcing a bearish trend. The recent 60-day high of 180.65 and low of 162.7 indicates a range-bound market with potential for a rebound.

Directional Bias: Given the current RSI and proximity to the 60-day low, there is a potential for a bullish reversal. 

Trade Plan:
- Suggested Entry: $168.50
- Stop Loss: $162.00 (below the 60D low)
- Take Profit Targets:
  1. $175.00 (Target 1, 3.0% gain)
  2. $180.00 (Target 2, 6.9% gain)
  3. $197.00 (Target 3, 17.1% gain)

This trade plan provides a structured approach with a favorable risk-reward ratio. Monitor closely for market changes.

https://privateprofiteers.com

Privateprofiteers

Private Profiteers | Elite Stock Analysis

StockTwits Web

Atmos Energy Corp.

 is currently trading at $168.21, showing a bearish sentiment as indicated by the RSI of 38.82, suggesting oversold conditions. The stock is below both the 30-day MA of 173.03 and the 50-day MA of 174.04, reinforcing a bearish trend. The recent 60-day high of 180.65 and low of 162.7 indicates a range-bound market with potential for a rebound.

Directional Bias: Given the current RSI and proximity to the 60-day low, there is a potential for a bullish reversal. 

Trade Plan:
- Suggested Entry: $168.50
- Stop Loss: $162.00 (below the 60D low)
- Take Profit Targets:
  1. $175.00 (Target 1, 3.0% gain)
  2. $180.00 (Target 2, 6.9% gain)
  3. $197.00 (Target 3, 17.1% gain)

This trade plan provides a structured approach with a favorable risk-reward ratio. Monitor closely for market changes.

